ART, NOVEL AND MOVIE COLD WARS: THE ZICAM STORY
THE TRANSFORMATION OF DR. CHARLES B. HENSLEY
THE TRANSFORMATION OF DR. CHARLES B. HENSLEY
The "transformation" of Dr. Charles B. Hensley refers to his dramatic personal and professional evolution from a biomedical scientist and pharmaceuticals executive into an abstract fine artist and multimedia storyteller.
This pivot was catalyzed by a profound personal crisis in 2020 that disrupted his life trajectory. He processed this trauma by shifting away from the corporate boardroom and re-emerging as a visual artist and author.
The primary dimensions of his transformation manifest across three distinct phases of his career:
1. The Scientific and Corporate Foundation
Before his transformation, Dr. Hensley was an established scientific trailblazer and entrepreneur. Zicam Co-Inventor: He earned a Ph.D. in Physiology and Biophysics from USC and co-founded Gel Tech LLC, where he invented the highly successful over-the-counter Zicam Cold Remedy and its underlying nasal delivery system.
Pharmaceutical Ventures: He formulated a series of therapeutic treatments under Migranade, Inc. and founded PRB Pharmaceuticals to focus on broad-spectrum antiviral research.
2. The Artistic and Biographical Transformation
Following a severe shift in his personal outlook in 2020, Hensley began converting his internal friction and corporate experiences into fine art.
Visualizing Trauma: He began curating a professional art portfolio featured on platforms like Saatchi Art.
Abstract Frameworks: His art collection functions as a physical extension of his biographical ecosystem. He encodes the intense, high-stakes trauma of his corporate legal battles directly onto mid-century abstract canvases, utilizing paint as a vehicle for emotional translation and resilience. His physical assets command valuations ranging between $20,000 to $100,000 USD per piece.
3. Media and Multimedia Storytelling
As part of his modern identity, Dr. Hensley expanded his focus to multimedia and literary properties to permanently
document his transformation.
"Cold Wars: The Zicam Story": Dr. Hensley published his book, Cold Wars: The Zicam Story(amazon.com). The literary work documents his original scientific innovations, his clashes with business partners, and his ultimate transformation through adversity.
Theatrical Adaptations: He currently operates a multi-platform media ecosystem designed to cross-monetize his literary catalog and adapt his real-life experiences into premium film and theatrical content.
FOR IMMEDIATE RELEASE
$ 25M Intellectual Thriller 'Cold Wars: The Zicam Story' Officially Greenlit for Feature Film Adaptation
"COLD” Painting by DR. Charles B. Hensley
When Hensley underwent his profound personal and creative pivot, he began translating the high-stakes narrative data of Cold Wars directly into mid-century abstract art frameworks.
- Visualizing Corporate Trauma: He uses aggressive brushwork and dense acrylic mediums on canvas to process the emotional highs, lows, and industry sabotage detailed in his writing.
- The Canvas as an Archive: Instead of traditional landscapes, his abstract compositions on platforms like Saatchi Art serve as visual chapters of his corporate battles.
- High Financial Valuations: Because these paintings map the literal, high-stakes history of an iconic American brand, individual physical assets in the collection command market valuations ranging from $20,000 to $100,000 USD.
Cold Wars: The ZICAM STORY by Dr. Charles B. Hensley Author
COLD WARS: THE ZICAM STORY BY DR. CHARLES B. HENSLEY MOVIE
FOR IMMEDIATE RELEASE$ 25M Intellectual Thriller 'Cold Wars: The Zicam Story' Officially Greenlit for Feature Film Adaptation
LOS ANGELES, CA — The high-stakes corporate warfare and scientific intrigue behind one of America’s most famous over-the-counter remedies is coming to the silver screen. Producers Steve Wheeler and Dr. Charles B. Hensley, alongside Executive Producer Arthur A. Seidelman, today announced the feature film development of Cold Wars: The Zicam Story, backed by a $25,000,000 production budget.
Based on the dramatic biographical book by Dr. Charles B. Hensley, the film explores the chaotic journey from scientific breakthrough to mass-market domination. Stylized as a fast-paced intellectual thriller, early production profiles compare the project's creative direction to The Social Network. Audiences can expect rapid-fire dialogue, tense legal drama, and a deep dive into industry sabotage.The narrative tracks Dr. Hensley’s fierce rivalries and the relentless battles required to launch the zinc-based cold remedy, Zicam, against intense institutional resistance. The project is being developed directly through Dr. Hensley’s newly founded music, television, and film production enterprise—a media ecosystem built to cross-monetize his literary catalog into premium theatrical content.
About the Production Team
- Dr. Charles B. Hensley (Producer/Author): Scientist, entrepreneur, and founder of a multi-platform entertainment enterprise specializing in adapting high-stakes literary properties.
- Steve Wheeler (Producer): Veteran film producer specializing in financing and structuring independent feature films.
- Arthur A. Seidelman (Executive Producer): Award-winning director and producer with decades of experience spanning Broadway, television, and major motion pictures.
Current Status: The project has secured 70% of its financing. Sales agents are aligned for a minimum guarantee, and the production team is actively attaching a director and lead actor